Work

Imaging and biomarker factors for predicting durable responses to 177Lu-PSMA therapy in metastatic castration resistant prostate cancer (mCRPC).

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17070

Authors: Alin Chirindel, Guillaume Nicolas, Abdel B. Halim, Mark S. Kidd

Institutions: University Hospital of Basel, Wren Laboratories (United States)

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410809341

FWCI:

Cites:

Cited by:

Related to: 10